These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era. Jalali A, Ha FJ, Chong G, Grigg A, Mckendrick J, Schwarer AP, Doig R, Hamid A, Hawkes EA. Ann Hematol; 2016 Apr 20; 95(5):809-16. PubMed ID: 26878861 [Abstract] [Full Text] [Related]
8. Risk-adapted therapy with three or six cycles of doxorubicin/bleomycin/vinblastine/dacarbazine plus involved-field radiation therapy in Hodgkin lymphoma, based on prognosis at diagnosis and early response: results from the GATLA study. Pavlovsky S, Corrado C, Pavlovsky MA, Prates MV, Zoppegno L, Giunta M, Cerutti I, Palomino E, Pagani F, Lastiri F, Bar D, Bezares RF, Avila G. Clin Lymphoma Myeloma Leuk; 2010 Jun 20; 10(3):181-5. PubMed ID: 20511162 [Abstract] [Full Text] [Related]
9. A randomized trial of brief treatment of early- stage Hodgkin lymphoma: Is it effective? Hamed RH, Anter AH, Awad IA. Hematol Oncol Stem Cell Ther; 2012 Jun 20; 5(1):36-41. PubMed ID: 22446609 [Abstract] [Full Text] [Related]
14. Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma. Filippi AR, Ciammella P, Piva C, Ragona R, Botto B, Gavarotti P, Merli F, Vitolo U, Iotti C, Ricardi U. Int J Radiat Oncol Biol Phys; 2014 Jun 01; 89(2):370-5. PubMed ID: 24613810 [Abstract] [Full Text] [Related]
15. Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapy. Bartlett NL. Am Soc Clin Oncol Educ Book; 2013 Jun 01; ():374-80. PubMed ID: 23714551 [Abstract] [Full Text] [Related]
16. Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial. André MPE, Girinsky T, Federico M, Reman O, Fortpied C, Gotti M, Casasnovas O, Brice P, van der Maazen R, Re A, Edeline V, Fermé C, van Imhoff G, Merli F, Bouabdallah R, Sebban C, Specht L, Stamatoullas A, Delarue R, Fiaccadori V, Bellei M, Raveloarivahy T, Versari A, Hutchings M, Meignan M, Raemaekers J. J Clin Oncol; 2017 Jun 01; 35(16):1786-1794. PubMed ID: 28291393 [Abstract] [Full Text] [Related]
17. Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study. Hentrich M, Berger M, Wyen C, Siehl J, Rockstroh JK, Müller M, Fätkenheuer G, Seidel E, Nickelsen M, Wolf T, Rieke A, Schürmann D, Schmidmaier R, Planker M, Alt J, Mosthaf F, Engert A, Arasteh K, Hoffmann C. J Clin Oncol; 2012 Nov 20; 30(33):4117-23. PubMed ID: 23045592 [Abstract] [Full Text] [Related]
18. Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need? Laskar S, Gupta T, Vimal S, Muckaden MA, Saikia TK, Pai SK, Naresh KN, Dinshaw KA. J Clin Oncol; 2004 Jan 01; 22(1):62-8. PubMed ID: 14657226 [Abstract] [Full Text] [Related]
19. Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma. Paumier A, Ghalibafian M, Beaudre A, Ferreira I, Pichenot C, Messai T, Lessard NA, Lefkopoulos D, Girinsky T. Int J Radiat Oncol Biol Phys; 2011 May 01; 80(1):199-205. PubMed ID: 21481723 [Abstract] [Full Text] [Related]
20. Involved node radiation therapy: an effective alternative in early-stage hodgkin lymphoma. Maraldo MV, Aznar MC, Vogelius IR, Petersen PM, Specht L. Int J Radiat Oncol Biol Phys; 2013 Mar 15; 85(4):1057-65. PubMed ID: 23200817 [Abstract] [Full Text] [Related] Page: [Next] [New Search]